Language Matters: Exploring the Impact of Language Concordance on Fertility Treatment Progression
ImpaLa
1 other identifier
interventional
70
1 country
1
Brief Summary
Currently, patients presenting to the Fertility and Reproductive Medicine Center meet with an English-speaking provider and communicate through an interpreter, as none of the physicians speak Spanish. However, this study PI is a native Spanish speaker and certified bilingual clinician. Thus, this study is looking to evaluate whether or not the use of an interpreter delays completion of testing and initiation of fertility treatment. The medically indicated testing, procedures, and course of treatment will not be altered as a result of participation in the study. Participants will be asked to complete a survey in their preferred language to gauge satisfaction and communication efficacy. This proposed study is significant as it seeks to address a critical gap in the understanding of how language concordance between healthcare providers and patients influences treatment outcomes in fertility care. With Spanish being the most commonly spoken non-English language in the U.S., evaluating the impact of Spanish language skills in medical care is both timely and essential. This research will shed light on whether Spanish-speaking patients experience better treatment progression and outcomes when cared for by language-concordant providers versus when interpreters are used in fertility care. This prospective study will be conducted at Washington University's Fertility and Reproductive Medicine Center over a 12-month period. The investigators aim to enroll a total of 70 Spanish-speaking patients, based on previous patient trends at the Center 35 will be randomized to the intervention group (being evaluated and treated by a Spanish-speaking provider), and 35 will be randomized to standard of care (communicating with an English-speaking provider through an interpreter).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 30, 2024
CompletedFirst Posted
Study publicly available on registry
October 15, 2024
CompletedStudy Start
First participant enrolled
October 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2025
CompletedMarch 28, 2025
March 1, 2025
12 months
September 30, 2024
March 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Completion of diagnostic tests
The primary outcome is the time from the patients initial consultation to the completion of the recommended fertility diagnostic tests such as blood work or a pelvic ultrasound. Given that the tests are typically specific to the menstrual cycle, the investigators want know if the patients are completing their work-up faster when they see a Spanish-speaking physician thus understanding the instructions versus when the English speaking providers use an interpreter. The work-up only includes the labs and imaging that was recommended during their initial visit. The outcome will be measured by the unit - days.
90 days from initial consultation.
Secondary Outcomes (1)
Patient satisfaction and communication
90 days from initial consultation.
Study Arms (2)
Spanish speaking patients seen by English-Speaking Provider
NO INTERVENTIONSpanish speaking patients will be seen by our English-speaking providers using a qualified interpreter.
Spanish-Speaking patients seen by a Spanish-speaking provider
EXPERIMENTALSpanish speaking patients will be seen by our Spanish-speaking provider
Interventions
Spanish speaking patients will be seen by our Spanish-speaking provider
Eligibility Criteria
You may qualify if:
- Must be greater than 18 years old
- Preferred language must be Spanish speaking
- Must be seeking fertility treatment
You may not qualify if:
- Preferred language English
- Not currently seeking fertility care
- Less than 18 years old
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Washington University in St Louis
St Louis, Missouri, 63108, United States
Related Publications (3)
Jain M, Peterson A, Nguyen N, Goldsammler M. Reproductive inequity and inferior intrauterine insemination outcomes in patients with limited English proficiency: a retrospective cohort study. Fertil Steril. 2023 Oct;120(4):844-849. doi: 10.1016/j.fertnstert.2023.05.154. Epub 2023 May 22.
PMID: 37225071BACKGROUNDLopez Vera A, Thomas K, Trinh C, Nausheen F. A Case Study of the Impact of Language Concordance on Patient Care, Satisfaction, and Comfort with Sharing Sensitive Information During Medical Care. J Immigr Minor Health. 2023 Dec;25(6):1261-1269. doi: 10.1007/s10903-023-01463-8. Epub 2023 Feb 25.
PMID: 36840903BACKGROUNDBerdahl TA, Kirby JB. Patient-Provider Communication Disparities by Limited English Proficiency (LEP): Trends from the US Medical Expenditure Panel Survey, 2006-2015. J Gen Intern Med. 2019 Aug;34(8):1434-1440. doi: 10.1007/s11606-018-4757-3. Epub 2018 Dec 3.
PMID: 30511285BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 30, 2024
First Posted
October 15, 2024
Study Start
October 15, 2024
Primary Completion
September 30, 2025
Study Completion
December 30, 2025
Last Updated
March 28, 2025
Record last verified: 2025-03